Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Haleon US Holdings LLC has 5 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 5 distinct examiners and 5 distinct art units, indicating that prosecution is distributed across separate examination assignments.
ROBERTS, ANNA L is the busiest examiner, with 1 pending office action. Portfolio oversight should emphasize assignment-specific deadlines and arguments while preserving consistency in the biotechnology and pharmaceutical claim positions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBERTS, ANNA L | 1 | 55.7% | +39.8% |
| ORTIZ, RAFAEL ALFREDO | 1 | 61.3% | +35.1% |
| GANGLE, BRIAN J | 1 | 76.8% | +14.6% |
| PEEBLES, KATHERINE | 1 | 35.6% | +48.0% |
| CAIN, JENNIFER LYNN | 1 | 43.5% | +67.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18852029 | METHOD FOR STRESS REDUCTION | ROBERTS, ANNA L | — |
| 18720722 | A CONNECTED CONTAINER SYSTEM | ORTIZ, RAFAEL ALFREDO | — |
| 18719308 | A NUTRITIONAL SUPPLEMENT FOR IMPROVED GUT HEALTH | GANGLE, BRIAN J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918790 | NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITS | PEEBLES, KATHERINE | 114d overdue |
| 17718624 | PRE-MOISTENED WIPES FOR USE IN TREATING ANAL RECTAL IRRITATIONS AND DISORDERS | CAIN, JENNIFER LYNN | 30d overdue |
| 18852029 | METHOD FOR STRESS REDUCTION | ROBERTS, ANNA L | — |
| 18720722 | A CONNECTED CONTAINER SYSTEM | ORTIZ, RAFAEL ALFREDO | — |
| 18719308 | A NUTRITIONAL SUPPLEMENT FOR IMPROVED GUT HEALTH | GANGLE, BRIAN J | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 3736 | 1 |
| 1645 | 1 |
| 1617 | 1 |
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18852029 | METHOD FOR STRESS REDUCTION | ROBERTS, ANNA L | 3791 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18720722 | A CONNECTED CONTAINER SYSTEM | ORTIZ, RAFAEL ALFREDO | 3736 | §102§112 | Final Rejection | — | Pending | Jun 17, 2024 |
| 18719308 | A NUTRITIONAL SUPPLEMENT FOR IMPROVED GUT HEALTH | GANGLE, BRIAN J | 1645 | §102§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 17918790 | NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITS | PEEBLES, KATHERINE | 1617 | §103 | Final Rejection | 114d overdue | Pending | Oct 13, 2022 |
| 17718624 | PRE-MOISTENED WIPES FOR USE IN TREATING ANAL RECTAL IRRITATIONS AND DISORDERS | CAIN, JENNIFER LYNN | 1655 | §103DP | Non-Final OA | 30d overdue | Pending | Apr 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHaleon US Holdings LLC has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Anna L Roberts has the most, with 1 of Haleon US Holdings LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
